[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352343-105":59,"doc-detail-352343-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","overexpression-of-gper1-suppressed-esophageal-carcinoma-growth-via-activating-camp-pathway","Overexpression of GPER1 suppressed esophageal carcinoma growth via activating cAMP pathway","","G protein-coupled estrogen receptor 1 (GPER1) acts as a tumor regulator in multiple cancers, yet its function in esophageal cancer (EC) is unclear. This study assessed GPER1 expression and prognostic value using the TCGA database, then validated findings in EC cells and fresh tissues. GPER1 was reduced in EC, and lower levels predicted poor overall survival. Gain-of-function experiments showed inhibited proliferation, enhanced apoptosis, increased ROS and Fe2+, and ferroptosis marker shifts, with H89 reversing cAMP-dependent ferroptotic effects. In vivo, GPER1 overexpression suppressed tumor growth, reduced Ki-67, and increased cell death. Overexpression of GPER1 enhances ferroptosis in EC primarily by activating the cAMP signaling pathway.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/overexpression-of-gper1-suppressed-esophageal-carcinoma-growth-via-activating-camp-pathway/352343/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/overexpression-of-gper1-suppressed-esophageal-carcinoma-growth-via-activating-camp-pathway/352343.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was GPER1 expression in esophageal cancer evaluated?","Question",{"text":112,"@type":113},"GPER1 expression and prognostic value were analyzed using the TCGA database and then verified in EC cells and fresh tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What effects did GPER1 overexpression have on EC cells in vitro?",{"text":117,"@type":113},"GPER1 overexpression decreased proliferation, increased apoptosis, increased ROS generation and Fe2+ content, and shifted ferroptosis-related markers including increased ACSL4 and decreased GPX4.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the cAMP pathway relate to GPER1-induced ferroptosis?",{"text":121,"@type":113},"Inhibiting cAMP/PKA with H89 significantly reversed ferroptotic effects triggered by GPER1, indicating that the cAMP signaling pathway is essential for this process.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352343,1791179869,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","European Journal of Histochemistry 2026; volume 70:4422  \nOverexpression of GPER1 suppressed esophageal carcinoma growth via activating cAMP pathway  \nHongmei Yin,1,2 Xiumei Han,2 Qun Zhang,2 Duojie Li,2 Fan Wang1  \n1Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 2Department of Radiotherapy, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China  \nABSTRACT  \nG protein-coupled estrogen receptor 1 (GPER1) has extensively verified as a tumor regulator in various types of cancers. However, its role in esophageal cancer (EC) remains largely unclear. In this study, the expression and prognostic prediction value of GPER1 in EC was analyzed by using TCGA database and was verified in EC cells and fresh tissues. The results showed that GPER1 is decreased in EC cells and tissues, and lower GPER1 expression is associated with poor overall survival of EC patients. CCK-8 assay and flow apoptosis cytometry were applied to measure the ability of proliferation and apoptosis of EC cells with or without GPER1 overexpression. The levels of reactive oxygen species (ROS) and Fe2+ were determined by flow cytometry. Elisa and Western blotting were employed to measure the markers of ferroptosis and cyclic adenosine monophosphate (cAMP) pathway. The results of in vitro experiments indicated that overexpression of GPER1 caused decreased proliferation, increased cell apoptosis, ROS generation, Fe2+ content and acyl-CoA synthetase long-chain family member 4 (ACSL4) expression, while decreased glutathione peroxidase 4 (GPX4) expression. Notably, the cAMP/PKA inhibitor H89 significantly reversed the ferroptotic effects induced by GPER1, indicating the essential role of the cAMP pathway in this process. The weight and volumes of tumors were measured and Ki-67 and H&E staining were conducted to analyze the effect of GPER1 in vivo. The results of in vivo experiments indicated that overexpression of GPER1 resulted in restricted tumor growth, reduced Ki-67 expression and increased cell death. In conclusion, the expression of GPER1 is reduced in EC. Overexpression of GPER1 enhances ferroptosis in EC, primarily through activation of the cAMP signaling pathway.  \nKey words: G protein-coupled estrogen receptor 1; ferroptosis; esophageal carcinoma; GPX4 .  \nCorrespondence: Fan Wang, Department of Radiotherapy, The First Affiliated Hospital of Anhui Medical University,  \nNo. 218 Jixi Road, Hefei 233000, Anhui, [China. E-mail: wangfan6682024@163.com](China. E-mail: wangfan6682024@163.com)  \nContributions: Hongmei Yin, data analysis and interpretation, histological examination, writing-original draft preparation. Xiumei Han, Qun Zhang, Duojie Li, data analysis and interpretation. Fan Wang, histological examination, writing- original draft preparation. All authors read and approved the final version of the manuscript and agreed to be accountable for all aspects of the work.  \nConflict of interest: the authors declare no competing interests and all authors confirm accuracy.  \nEthics approval: this study was approved by the Clinical Research Ethics Committee of Bengbu Medical University (approval No. 2025-(Lunshen)-541). Informed consent was obtained from all participants. All animal experiments were approved by the Animal Ethics Committee of Bengbu Medical University (approval No. 2025-(Lunshen)-730) and were carried out in accordance with relevant guidelines and regulations.  \nAvailability of data and materials: all data is available upon reasonable request from the corresponding author.  \nFunding: this work was supported by the Natural Science General Program of Bengbu Medical University (No. 2024byzd061) and the Research Funds of Joint Research Center for Regional Diseases of IHM (No. 2024bydjk009) .  \n[European Journal of Histochemistry 2026; 70:4422]  \nIntroduction  \nEsophageal cancer (EC) ranks as the eighth most prevalent cancer and the sixth leading cause of cancer-related mortality globally.1,","cbCaicqo6xDyb0rM","https://ap.wps.com/l/cbCaicqo6xDyb0rM","pdf",1210862,12,"English","# Abstract\n# Introduction","[{\"question\":\"How was GPER1 expression in esophageal cancer evaluated?\",\"answer\":\"GPER1 expression and prognostic value were analyzed using the TCGA database and then verified in EC cells and fresh tissues.\"},{\"question\":\"What effects did GPER1 overexpression have on EC cells in vitro?\",\"answer\":\"GPER1 overexpression decreased proliferation, increased apoptosis, increased ROS generation and Fe2+ content, and shifted ferroptosis-related markers including increased ACSL4 and decreased GPX4.\"},{\"question\":\"How does the cAMP pathway relate to GPER1-induced ferroptosis?\",\"answer\":\"Inhibiting cAMP/PKA with H89 significantly reversed ferroptotic effects triggered by GPER1, indicating that the cAMP signaling pathway is essential for this process.\"}]","Overexpression of GPER1 suppressed esophageal carcinoma growth via activating cAMP pathway | PDF",1790099063,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31ad6a001a0cd26da42ebdadd76ff8a3.webp",983,1307,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/674ffa4b36a28cdfd8feb3c13051dc67.webp",982,1306,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/209f61411790d403b67f2a173a2f23a5.webp",981,1305,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7c00eb1b4228a32f35286d2d897a4d3.webp",980,1303]